96 related articles for article (PubMed ID: 7518576)
1. Allelic loss and somatic differentiation in human male germ cell tumors.
Murty VV; Bosl GJ; Houldsworth J; Meyers M; Mukherjee AB; Reuter V; Chaganti RS
Oncogene; 1994 Aug; 9(8):2245-51. PubMed ID: 7518576
[TBL] [Abstract][Full Text] [Related]
2. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
Mathew S; Murty VV; Bosl GJ; Chaganti RS
Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic changes in human male germ cell tumors.
Lothe RA; Peltomäki P; Tommerup N; Fosså SD; Stenwig AE; Børresen AL; Nesland JM
Lab Invest; 1995 Nov; 73(5):606-14. PubMed ID: 7474934
[TBL] [Abstract][Full Text] [Related]
5. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
Murty VV; Li RG; Houldsworth J; Bronson DL; Reuter VE; Bosl GJ; Chaganti RS
Oncogene; 1994 Nov; 9(11):3227-31. PubMed ID: 7936646
[TBL] [Abstract][Full Text] [Related]
6. A genetic perspective of male germ cell tumors.
Murty VV; Chaganti RS
Semin Oncol; 1998 Apr; 25(2):133-44. PubMed ID: 9562446
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
8. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.
Strohmeyer T; Reese D; Press M; Ackermann R; Hartmann M; Slamon D
J Urol; 1995 Feb; 153(2):511-5. PubMed ID: 7529338
[TBL] [Abstract][Full Text] [Related]
9. Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors.
Murty VV; Reuter VE; Bosl GJ; Chaganti RS
Oncogene; 1996 Jun; 12(12):2719-23. PubMed ID: 8700532
[TBL] [Abstract][Full Text] [Related]
10. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity at 11p loci in testicular cancer.
Smith RC; Rukstalis DB
J Urol; 1995 May; 153(5):1684-7. PubMed ID: 7715010
[TBL] [Abstract][Full Text] [Related]
13. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
14. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
15. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
16. Instability at the W/c-kit locus in mice: analysis of melanocyte cell lines derived from reversion spots.
De Sepulveda P; Peyrieras N; Panthier JJ
Oncogene; 1994 Sep; 9(9):2655-61. PubMed ID: 7520149
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
Hines SJ; Organ C; Kornstein MJ; Krystal GW
Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
[TBL] [Abstract][Full Text] [Related]
18. Allelotype analysis of cervical carcinoma.
Mitra AB; Murty VV; Li RG; Pratap M; Luthra UK; Chaganti RS
Cancer Res; 1994 Aug; 54(16):4481-7. PubMed ID: 8044799
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
20. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
